PBM – psyence biomedical ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Psyence BioMed Announces Approval for Use of PsyLabs' Psilocybin Product in Phase IIb Clinical Trial [Yahoo! Finance]
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial [Canadian Business Journal (Canada)]
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science
Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program [Canadian Business Journal (Canada)]
Form SCHEDULE 13D PSYENCE BIOMEDICAL LTD. Filed by: Kaos Capital Ltd
Form 6-K PSYENCE BIOMEDICAL LTD. For: Nov 21
Form 424B3 PSYENCE BIOMEDICAL LTD.
Form 6-K PSYENCE BIOMEDICAL LTD. For: Sep 30
Form 424B3 PSYENCE BIOMEDICAL LTD.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.